BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23154766)

  • 1. Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count.
    Adsay V
    Am J Surg Pathol; 2012 Dec; 36(12):1743-6. PubMed ID: 23154766
    [No Abstract]   [Full Text] [Related]  

  • 2. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
    Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
    Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controversies of gastroenteropancreatic neuroendocrine tumor pathology diagnosis].
    Sasano H; Kasajima A
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2280-5. PubMed ID: 25482903
    [No Abstract]   [Full Text] [Related]  

  • 4. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
    Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
    Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Cytotechnologist Manual Counting Service for the Ki67 Index in Neuroendocrine Tumors of the Pancreas and Gastrointestinal Tract.
    Cottenden J; Filter ER; Cottreau J; Moore D; Bullock M; Huang WY; Arnason T
    Arch Pathol Lab Med; 2018 Mar; 142(3):402-407. PubMed ID: 29293020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 labeling: a more sensitive indicator of malignant phenotype than mitotic count or tumor size?
    Lowe K; Khithani A; Liu E; Winston T; Christian D; Saad J; Jeyarajah DR
    J Surg Oncol; 2012 Nov; 106(6):724-7. PubMed ID: 22549809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.
    Ozturk Sari S; Taskin OC; Gundogdu G; Yegen G; Onder S; Keskin M; Saglam S; Ozluk Y; Gulluoglu M; Mete O
    Endocr Pathol; 2016 Jun; 27(2):162-70. PubMed ID: 26936845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accurate grading of pancreatic neuroendocrine tumors with Ki-67 index in fine-needle aspiration specimens: a comparative cytologic and histologic study].
    He SR; Cui D; Gong H; Zhu YP; Chen L; Hu ST; Liu DG
    Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):393-399. PubMed ID: 28591986
    [No Abstract]   [Full Text] [Related]  

  • 9. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
    Murphy CE; McCormick KA; Shankaran V; Reddi DM; Swanson PE; Upton MP; Papanicolau-Sengos A; Khor S; Westerhoff M
    Pancreas; 2017; 46(10):1359-1365. PubMed ID: 29040195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic characteristics of pancreatic neuroendocrine neoplasm].
    Okuwaki K; Kida M; Imaizumi H; Yamauchi H; Koizumi W
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():788-91. PubMed ID: 25857136
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors.
    Hasegawa T; Yamao K; Hijioka S; Bhatia V; Mizuno N; Hara K; Imaoka H; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Kinoshita T; Kohsaki T; Nishimori I; Iwasaki S; Saibara T; Hosoda W; Yatabe Y
    Endoscopy; 2014 Jan; 46(1):32-8. PubMed ID: 24218309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic count by phosphohistone H3 immunohistochemical staining predicts survival and improves interobserver reproducibility in well-differentiated neuroendocrine tumors of the pancreas.
    Voss SM; Riley MP; Lokhandwala PM; Wang M; Yang Z
    Am J Surg Pathol; 2015 Jan; 39(1):13-24. PubMed ID: 25353284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.
    Boukhar SA; Gosse MD; Bellizzi AM; Rajan K D A
    Am J Clin Pathol; 2021 Sep; 156(4):607-619. PubMed ID: 33847759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?
    Satturwar SP; Pantanowitz JL; Manko CD; Seigh L; Monaco SE; Pantanowitz L
    Cancer Cytopathol; 2020 Aug; 128(8):535-544. PubMed ID: 32401429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKX6-1 Is a Novel Immunohistochemical Marker for Pancreatic and Duodenal Neuroendocrine Tumors.
    Tseng IC; Yeh MM; Yang CY; Jeng YM
    Am J Surg Pathol; 2015 Jun; 39(6):850-7. PubMed ID: 25871618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.
    Reid MD; Bagci P; Ohike N; Saka B; Erbarut Seven I; Dursun N; Balci S; Gucer H; Jang KT; Tajiri T; Basturk O; Kong SY; Goodman M; Akkas G; Adsay V
    Mod Pathol; 2015 May; 28(5):686-94. PubMed ID: 25412850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of Ki-67 immunostaining.
    Jamali M; Chetty R
    Endocr Pathol; 2008; 19(4):282-8. PubMed ID: 18931958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease.
    Singh S; Hallet J; Rowsell C; Law CH
    Eur J Surg Oncol; 2014 Nov; 40(11):1517-22. PubMed ID: 25088936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.